Growing Regenerative Drug Pipeline Presents Opportunities in Bone and Joint Applications

company logo

Global regenerative drugs market

Global regenerative drugs market

Global regenerative drugs market

Dublin, June 24, 2022 (GLOBE NEWSWIRE) — The “Regenerative medicines: bone and joint applications” report has been added to from offer.

Key players

  • Anika Therapeutics Inc.

  • Arthrex inc.

  • Baxter International Inc.

  • Bioventus

  • Conmed Corp.

  • Depuy Synthes Products Inc. (part of Johnson & Johnson)

  • Medtronic plc

  • Seikagaku Corp.

  • Smith & Nephew plc

  • Stryker Corp.

  • Zimmer Biomet Holdings Inc.

The report includes

  • An overview of the global market for regenerative drugs for bone and joint applications

  • Market size estimation and global market trend analyses, with data from 2020 to 2021, estimates to 2022, with compound annual growth rate (CAGR) projections to 2027

  • Characterization and quantification of the regenerative drugs market potential by technology, application and region

  • Industry coverage and discussion of COVID-19 regulatory delays, clinical trials and product launches

  • Description of the main approaches of regenerative medicine and discussion of the importance of scaffolding in tissue engineering

  • Information on key drivers and regional market dynamics and current trends within the industry

  • Analysis of market shares of key companies in the sector and coverage of events such as mergers and acquisitions, joint ventures, collaborations or partnerships and other key market strategies

Reasons for doing this study:

The purpose of this report is to provide a summary of regenerative medicine products for the treatment of bone and joint diseases and disorders. Regenerative therapies have the potential to advance medical outcomes, improve quality of life, and reduce overall healthcare costs.

A major goal is the use of living cells to repair or replace body tissue damaged by injury, disorder, or the aging process. The most successful products appeal to multidisciplinary fields such as biology, medicine, engineering and, in particular, biomedical engineering.

This report is designed to be an essential decision-making tool for the intended audience, which includes Biopharmaceutical market players, potential market entrants, and other professionals involved or interested in Cell and Gene Therapy and Regenerative Therapy in the Orthopedic sector .

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Overview of Regenerative Medicine

  • How Regenerative Medicine Works

  • Main approaches of regenerative medicine

  • Cells and tissues

  • Creation of fabrics

  • Importance of scaffolding in tissue engineering

  • plastic scaffolding

  • Scaffolding of blood vessels

  • Center for the Integration of Medicine and Innovative Technologies (Cimit)

  • Embryonic stem cells

Chapter 4 Impact of Covid-19

  • Insight

  • Impact of Covid-19 on cell and gene therapies and regenerative medicine for bone and joint applications

  • Direct impact on clinical trials in cell and gene therapy

Chapter 5 Market Dynamics

  • Market factors

    • Growing number of bone and joint disorders and orthopedic surgeries

    • Increase product approvals and launches

    • R&D for stem and gene therapies

  • Market constraints

  • Market opportunities

  • Competitive landscape

Chapter 6 Market Breakdown by Technology

Chapter 7 Market Split by Application

Chapter 8 Market Breakdown by Region

For more information on this report, visit


CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Leave a Comment